ESSIX BIOSCIENCES LIMITED's most recent trade in Ind-Swift Laboratories Ltd. was a Acquisition of 1,100,000 Equity Shares done at an average price of Rs. 121 . Disclosure was reported to the exchange on July 5, 2025 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
No reported SAST transactions available for ESSIX BIOSCIENCES LIMITED in the Trendlyne database.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ind-Swift Laboratories | Essix Biosciences Limited | Promoter | Acquisition | 05 Jul 2025 | 1,100,000 | 23,427,507 (34.86%) | 1.64% | 121 | 133,100,000 | 02 Jul 2025 02 Jul 2025 |
Insider Trading | Equity Shares | Conversion of security |
| Ind-Swift Laboratories | Essix Biosciences Limited | Promoter | Acquisition | 03 Sep 2024 | 8,000,000 | 8,000,000 (9.40%) | 13.54% | 121 | 968,000,000 | 30 Aug 2024 30 Aug 2024 |
Insider Trading | Warrants | Allotment |
| Ind-Swift Laboratories | ESSIX BIOSCIENCES LIMITED | Promoter | Acquisition | 03 Apr 2024 | 9,499,720 | 22,327,507 (37.79%) | 16.08% | 101 | 959,471,720 | 28 Mar 2024 28 Mar 2024 |
Insider Trading | Equity Shares | Inter-se Transfer |